Vimentin Expression in Nasal Mucosa of Patients with Exacerbated Chronic Rhinosinusitis Without Nasal Polyps

1. Kim DK, Jin HR, Eun KM et al. The role of interleukin-33 in chronic rhinosinusitis. Thorax. 2017; 72(7): 635-645.10.1136/thoraxjnl-2016-20877227885166Search in Google Scholar

2. Lam K, Schleimer R, Kern RC. The etiology and pathogenesis of chronic rhinosinusitis: a review of current hypotheses. Current allergy and asthma reports. 2015; 15(7): 41.10.1007/s11882-015-0540-2487449126143392Search in Google Scholar

3. Lin H, Lin D, Xiong XS, et al. Expression and regulation of interleukin-9 in chronic rhinosinusitis. Am J Rhinol Allergy. 2015; 29(1): e18-23.10.2500/ajra.2015.29.413625590309Search in Google Scholar

4. DeConde AS, Soler ZM. Chronic rhinosinusitis: Epidemiology and burden of disease. Am J Rhinol Allergy. 2016; 30(2): 134-9.10.2500/ajra.2016.30.429726980394Search in Google Scholar

5. Beule A. Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities, and economic burden. GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery. 2015; 14: Doc11.Search in Google Scholar

6. Hastan D, Fokkens WJ, Bachert C et al. Chronic rhinosinusitis in European underestimated disease. A GA2LEN study. Allergy. 2011; 66(9): 1216-23.10.1111/j.1398-9995.2011.02646.x21605125Search in Google Scholar

7. Rudmik L. Economics of chronic rhinosinusitis. Curr Allergy Asthma Rep. 2017; 17(4) :20. doi: 10.1007/s11882-017-0690-5.10.1007/s11882-017-0690-528337570Open DOISearch in Google Scholar

8. Smith KA, Orlandi RR, Rudmik L. Cost of adult chronic rhinosinusitis: A systematic review.Laryngoscope. 2015; 125(7): 1547-56.10.1002/lary.2518025640115Search in Google Scholar

9. Cho S-W, Kim DW, Kim J-W et al. Classification of chronic rhinosinusitis according to a nasal polyp and tissue eosinophilia: limitation of current classification system for Asian population. Asia Pacific Allergy. 2017; 7(3): 121-130.10.5415/apallergy.2017.7.3.121553707628765816Search in Google Scholar

10. Kato A. Immunopathology of chronic rhinosinusitis. Allergology international: official journal of the Japanese Society of Allergology. 2015; 64(2): 121-130.10.1016/j.alit.2014.12.006467565725838086Search in Google Scholar

11. Cao PP, Li HB, Wang BF et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol. 2009; 124: 478-484. 484. e1-484.e2.10.1016/j.jaci.2009.05.01719541359Search in Google Scholar

12. Fokkens WJ, Lund VJ, Mullol J et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012; 50(1): 1-12.10.4193/Rhino12.00022469599Search in Google Scholar

13. Li X, Tao Y, Li X. Expression of MMP-9/TIMP-2 in nasal polyps and its functional implications. International Journal of Clinical and Experimental Pathology. 2015; 8(11): 14556-14561.Search in Google Scholar

14. Jabłońska-Trypuć A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016; 31(sup1): 177-183.10.3109/14756366.2016.116162027028474Search in Google Scholar

15. Bachert C, Pawankar R, Zhang L et al. ICON: chronic rhinosinusitis. The World Allergy Organization Journal. 2014; 7:25.10.1186/1939-4551-7-25421358125379119Search in Google Scholar

16. Bai X, Li YY, Zhang HY et al. Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial–mesenchymal transition in esophageal squamous cell carcinoma. Onco Targets and therapy. 2017; 10: 2837-2847.10.2147/OTT.S134813547677328652766Search in Google Scholar

17. Lin CY, Tsai PH, Kandaswami CC et al. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci. 2011; 102(4): 815-27.10.1111/j.1349-7006.2011.01861.x21219539Search in Google Scholar